Besides, positive rates of CEA, CYFRA21‐1, and NSE (56.6%, 42.1%, and 34.9%, respectively) were significantly lower than SP70 in NSCLC (χ2 = 24.736, P < .001). The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.